Written by Support on 11 October 2018. Posted in Press Releases and Ad-hoc Announcements.

AH: Partner Magenta Therapeutics Exercises Option To Further Develop a Target Molecule as Antibody Targeted Amanitin Conjugate

• PDF File: images/files//2022/20181110_ah_hdp_magenta_option_engl_final.pdf
• Datum: Thursday, 11 October 2018 12:03

2018

• Created on 04 November 2021.
• Last updated on 04 November 2021.
• Hits: 1576